Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Company profile
Ticker
ZTEK, ZEN
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Element Solutions • Cabot • Orion S.A • Versum Materials • WD-40 • Arq • GlyEco • Flexible Solutions International • Flotek Industries • ASP Isotopes ...
SEC CIK
Latest filings (excl ownership)
6-K
Zentek Provides ZenGUARD™ Business Update
25 Apr 24
F-3/A
Shelf registration (foreign) (amended)
24 Apr 24
F-3
Shelf registration (foreign)
23 Apr 24
6-K
Zentek Announces U.S. Distribution Agreement
3 Apr 24
6-K
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
25 Mar 24
6-K
Current report (foreign)
12 Feb 24
6-K
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
30 Jan 24
6-K
Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARDTM-Enhanced HVAC Filters
22 Jan 24
6-K
Zentek Announces Eric Wallman Appointed as Chairman of the Board
19 Jan 24
6-K
Current report (foreign)
13 Dec 23
Latest ownership filings
No filings
Financial summary
Quarter (USD) | Mar 23 | Mar 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Press releases
Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions
3 Apr 24
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
25 Mar 24
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
30 Jan 24